H.I.G. Realty Partners Expands European Team with the Addition of Jérome Fouillé and Jenny Hammarlund as Managing Directors
H.I.G. Capital (“H.I.G.”), a leading global alternative asset management firm with over $30 billion of equity capital under management, is pleased to announce that Jérome Fouillé and Jenny Hammarlund have joined the firm’s real estate team as Managing Directors. Jérome and Jenny together bring over 35 years of experience originating, structuring and investing in real estate equity and debt. They are based in H.I.G.'s London office.
Prior to H.I.G., Jérome worked for GIC as Managing Director and Head of Tactical Opportunities where he was responsible for investments in Europe targeting Core+ to Value Add transactions across a wide range of asset classes. Prior to this, he was a Senior Vice President at Colony Capital and at Heitman. Jérome holds an M.B.A. from The London Business School.
Prior to H.I.G., Jenny was a Director in the real estate team at KKR, where she focused on sourcing and executing real estate investments across Europe. Prior to this, Ms. Hammarlund was a Director at Värde Partners in London and a Vice President at Lehman Brothers Real Estate Partners in New York. Jenny holds an M.B.A. from Columbia Business School.
Riccardo Dallolio, Managing Director and Head of H.I.G. Europe Realty Partners, commented: "I am delighted to welcome Jenny and Jérome to the firm. They are very experienced and successful real estate investors who significantly augment the expertise and capabilities of our team. I am confident they will play an instrumental role in H.I.G. Realty’s growth in Europe."
About H.I.G. Capital
H.I.G. is a leading global private equity and alternative assets investment firm with over $30 billion of equity capital under management.* Based in Miami, and with European offices in London, Hamburg, Madrid, Milan, Paris, and U.S. and Latin American offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, Stamford, Bogotá, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/ value-added approach:
1. H.I.G.’s equity funds invest in growth investments, management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
2. H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance.
3. H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of $30 billion. For more information, please refer to the H.I.G. website at www.higcapital.com.
* Based on total capital commitments managed by H.I.G. Capital and affiliates.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
GLIDE and eBay Present the 20th Annual Auction for Power Lunch with Warren Buffett, May 26 – May 3120.5.2019 11:00:00 CEST | Pressemelding
GLIDE is pleased to announce the annual eBay for Charity Auction for Power Lunch with Warren Buffett, which will begin at 7:30 pm PDT on Sunday, May 26 and end at 7:30 pm PDT on Friday, May 31, 2019. This year marks the 20th anniversary of the legendary auction, which to date has provided nearly $30 million to support GLIDE’s comprehensive suite of social services that help San Francisco’s most vulnerable residents overcome hunger, poverty, homelessness and health challenges as well as social isolation and marginalization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005017/en/ “It makes a difference, and it translates into human beings finding that there is hope in life and that something better is there,” Mr. Buffett said recently about the money raised for GLIDE over the past 20 years. The annual Power Lunch with Warren Buffett is made possible through the support of eBay for Charity. The winning bidder and up to
PEI-Genesis Promotes Peter Austin to General Manager North America and Corporate Senior Vice President20.5.2019 11:00:00 CEST | Pressemelding
PEI-Genesis, the world’s fastest assembler of precision connectors, has promoted Peter Austin to General Manager North America and Corporate Senior Vice President, effective immediately. He will continue to report directly to Steven Fisher, PEI-Genesis Chairman and CEO. “Since joining PEI-Genesis in 2016, Peter has proven to be a valuable leader and an unparalleled strategic thinker in working to move the business forward,” said Fisher. “With his decades of experience in the electronics industry, his innovative thinking, and his ability to lead teams across North America, we have many accomplishments to tout, all directly related to his work.” In addition to his current responsibilities, in his new General Manager role, Austin will have responsibility for all operations in North America, including the company’s production facilities in South Bend, IN, Chandler, AZ, and Nogales, Mexico. He’ll also have leadership of the company’s North American Sales units. “My tenure at PEI has been a
Enlighted Expands IoT Platform Lighting Control Capabilities20.5.2019 10:00:00 CEST | Pressemelding
Enlighted, the leading provider of Internet of Things (IoT) solutions for commercial buildings and healthcare facilities, today announced new lighting control capabilities have been added to its award-winning building IoT Platform. These include advanced tunable white lighting control, daylight harvesting group capabilities, and a two-wire interface for the company’s powerful sensors. Together these new advancements improve the health and well-being of building occupants, improve lighting aesthetics, simplify fixture integration and reduce costs. Advanced Tunable White Lighting Control Enlighted sensors go beyond the automated circadian rhythm capabilities typically found in today’s tunable white solutions and now provide user-level control of color temperature to desired levels. The color temperature can be automatically aligned with the astronomical clock or directly tuned according to specific user needs. Occupants can tailor their environment, improve productivity and comfort, and
ams, Ibeo and ZF Partner to Deliver Industry-First Solid-State LiDAR Systems for the Automotive Industry20.5.2019 09:36:00 CEST | Pressemelding
ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces today that it has signed an agreement to team with Ibeo Automotive Systems GmbH, the German specialist for automotive LiDAR sensor technology, and ZF Friedrichshafen AG, one of the leading technology companies for mobility worldwide to advance solid-state LiDAR technology for use in autonomous driving and other applications. The three companies will partner on joint R&D efforts to ensure that this exciting technology can be quickly and safely adopted by 2021. LiDAR is an optical sensing technology that measures distance and direction of the surrounding objects by illuminating them with a laser beam and detecting the reflection of the object. Its unique range and resolution properties complement radar and camera solutions to enable the ‘Holy Grail’ of the self-driving car industry – SAE level 5* or fully autonomous driving. ams will provide automotive-grade VCSEL (Vertical Cavity Surface Emittin
Personalis, Inc. to Present at Advances in Immuno-Oncology Congress UK 201920.5.2019 07:05:00 CEST | Pressemelding
Personalis, Inc., a leader in advanced genomics for cancer, today announced that the company will present at Advances in Immuno-Oncology Congress UK 2019 in London on May 21st at 11:00 AM BST. The presentation, entitled “Advancing Precision Oncology Biomarker Discovery with a Multi-dimensional Immunogenomics Platform,” will introduce Personalis’ new universal cancer immunogenomics platform, ImmunoID NeXT™. In addition to an overview, the presentation will introduce preliminary data from an ongoing study in which this platform is being used to evaluate IO-related biomarkers and potential tumor escape mechanisms in a cohort of melanoma patients treated with anti-PD-1 therapy. ImmunoID NeXT™ is the first platform to provide comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The platform can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one. This maximizes the
New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery20.5.2019 07:00:00 CEST | Pressemelding
Masimo (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb® to help clincians estimate when to conduct invasive hemoglobin measurement to detect possible anemia in patients undergoing spine or cytoreductive surgery.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005244/en/ Masimo Radical-7® with SpHb® (Photo: Business Wire) Noting that because of the “invasive, time-consuming and intermittent” nature of invasive blood sampling, clincians often forgo these “objective indications” when making transfusion decisions during surgery, Dr. Tang and colleagues sought to determine whether noninvasive, continuous hemoglobin monitoring could aid clinicians in estimating when it might be appropriate to perform an invasive measurement. They enroll